Opioids remain the major medication for perioperative and chronic pain management, but their side effects, which include respiratory depression, constipation, addiction and others, relate to morbidity and mortality in our patients, as well as presenting a significant economic and political burden. Since both the analgesic and side effects are thought to arise from activation of the mu receptor (MUR), a better understanding of the structural and functional relationships of human MUR might provide clues for addressing this clinical dilemma. My long-term goal is to reveal the molecular recognition mechanism of opiates and opiate receptors by using biochemical, biophysical, protein engineering and the high resolution structural approaches. In this project, 4 specific aims are proposed.
In aim 1, we will establish a novel structural model of the human MUR from a combination of rhodopsin structural data and the newly available experimental structures of human ?2 adrenergic receptor. This will permit opioid and MUR interaction studies at the computational level.
In aim 2, we will engineer a variant of the water soluble, but structurally unaltered water soluble mu receptor (WSMUR) for dynamic opioid and receptor interactions in solution conditions.
In aim 3, we will express the WSMUR for biophysical characterization studies and for various binding studies with opioids in solution conditions.
In aim 4, we will crystallize the WSMUR for structural determinations in the presence or absence of opioids. As an anesthesiologist, formerly trained in academic centers in China, Japan, and United States, Dr. Liu is firmly committed to a career in academic anesthesia. His ultimate career goal is to achieve a better understanding of opioid and opioid receptor interactions, and use these data to develop optimal analgesics to ultimately improve patient care and satisfaction. This proposal will help him to reach his goals by providing further training and resources. His co-mentors have established records of nurturing junior faculty. Together with his current skill set, the advanced training enabled through the K-08 will help transition Dr. Liu towards an independent physician scientist in the area of perioperative medicine.
This project uses alternative structural approaches to investigate the relationship between opioids and human mu receptor. The information derived from this project may help to design novel opioid analgesics with minimal side effects, improve pain control, and solve issues related to opioids administration and abuse. Thus, this project has significant implications for public health.
|Zhao, Xuelian; Perez-Aguilar, Jose Manuel; Matsunaga, Felipe et al. (2014) Characterization of a computationally designed water-soluble human ?-opioid receptor variant using available structural information. Anesthesiology 121:866-75|
|Liu, Renyu; Huang, Xi-Ping; Yeliseev, Alexei et al. (2014) Novel molecular targets of dezocine and their clinical implications. Anesthesiology 120:714-23|
|Wu, Fei-Xiang; Pan, Rui-Rui; Yu, Wei-Feng et al. (2014) The Anti-Nociception Effect of Dezocine in a Rat Neuropathic Pain Model. Transl Perioper Pain Med 1:5-8|
|Sophocles, Aris; Chen, Linda; Lin, David et al. (2014) Postoperative amnesia in a patient undergoing general anesthesia for electro-physiologic (EP) catheter ablation of an irritable atrial focus. Transl Perioper Pain Med 1:35-38|
|Liu, Renyu (2014) The launch of the Translational Perioperative and Pain Medicine. Transl Perioper Pain Med 1:1-2|
|Xu, Longhe; Matsunaga, Felipe; Xi, Jin et al. (2014) n-Dodecyl *-D-maltoside specifically competes with general anesthetics for anesthetic binding sites. J Biomol Struct Dyn 32:1833-40|
|Lerner, Mitchell B; Matsunaga, Felipe; Han, Gang Hee et al. (2014) Scalable production of highly sensitive nanosensors based on graphene functionalized with a designed G protein-coupled receptor. Nano Lett 14:2709-14|
|Orton, Edward; Liu, Renyu (2014) Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans. Transl Perioper Pain Med 1:9-11|
|Cui, Xu; Yeliseev, Alexei; Liu, Renyu (2013) Ligand interaction, binding site and G protein activation of the mu opioid receptor. Eur J Pharmacol 702:309-15|
|Ji, Fang; Wang, Zhenhong; Ma, Nan et al. (2013) Herkinorin dilates cerebral vessels via kappa opioid receptor and cyclic adenosine monophosphate (cAMP) in a piglet model. Brain Res 1490:95-100|
Showing the most recent 10 out of 17 publications